DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3鈥� carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
The global market for Sanger Sequencing Service was estimated to be worth US$ 213.6 million in 2023 and is forecast to a readjusted size of US$ 212.5 million by 2030 with a CAGR of -0.2% during the forecast period 2024-2030
Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sanger Sequencing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sanger Sequencing Service by region & country, by Type, and by Application.
The Sanger Sequencing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sanger Sequencing Service.
Market Segmentation
By Company
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology
Segment by Type:
PCR Products
Plasmid DNA
Bacterial Artificial Chromosomes (BAC)
Others
Segment by Application
Research Institutions
Biotech Companies
Universities and Colleges
Hospitals and Clinics
Pharmaceutical Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sanger Sequencing Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Sanger Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Sanger Sequencing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Sanger Sequencing Service Product Introduction
1.2 Global Sanger Sequencing Service Market Size Forecast
1.3 Sanger Sequencing Service Market Trends & Drivers
1.3.1 Sanger Sequencing Service Industry Trends
1.3.2 Sanger Sequencing Service Market Drivers & Opportunity
1.3.3 Sanger Sequencing Service Market Challenges
1.3.4 Sanger Sequencing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sanger Sequencing Service Players Revenue Ranking (2023)
2.2 Global Sanger Sequencing Service Revenue by Company (2019-2024)
2.3 Key Companies Sanger Sequencing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sanger Sequencing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Sanger Sequencing Service
2.6 Sanger Sequencing Service Market Competitive Analysis
2.6.1 Sanger Sequencing Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sanger Sequencing Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sanger Sequencing Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PCR Products
3.1.2 Plasmid DNA
3.1.3 Bacterial Artificial Chromosomes (BAC)
3.1.4 Others
3.2 Global Sanger Sequencing Service Sales Value by Type
3.2.1 Global Sanger Sequencing Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sanger Sequencing Service Sales Value, by Type (2019-2030)
3.2.3 Global Sanger Sequencing Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institutions
4.1.2 Biotech Companies
4.1.3 Universities and Colleges
4.1.4 Hospitals and Clinics
4.1.5 Pharmaceutical Companies
4.1.6 Others
4.2 Global Sanger Sequencing Service Sales Value by Application
4.2.1 Global Sanger Sequencing Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sanger Sequencing Service Sales Value, by Application (2019-2030)
4.2.3 Global Sanger Sequencing Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sanger Sequencing Service Sales Value by Region
5.1.1 Global Sanger Sequencing Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sanger Sequencing Service Sales Value by Region (2019-2024)
5.1.3 Global Sanger Sequencing Service Sales Value by Region (2025-2030)
5.1.4 Global Sanger Sequencing Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sanger Sequencing Service Sales Value, 2019-2030
5.2.2 North America Sanger Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sanger Sequencing Service Sales Value, 2019-2030
5.3.2 Europe Sanger Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sanger Sequencing Service Sales Value, 2019-2030
5.4.2 Asia Pacific Sanger Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sanger Sequencing Service Sales Value, 2019-2030
5.5.2 South America Sanger Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sanger Sequencing Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Sanger Sequencing Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sanger Sequencing Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sanger Sequencing Service Sales Value
6.3 United States
6.3.1 United States Sanger Sequencing Service Sales Value, 2019-2030
6.3.2 United States Sanger Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sanger Sequencing Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sanger Sequencing Service Sales Value, 2019-2030
6.4.2 Europe Sanger Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sanger Sequencing Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sanger Sequencing Service Sales Value, 2019-2030
6.5.2 China Sanger Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sanger Sequencing Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sanger Sequencing Service Sales Value, 2019-2030
6.6.2 Japan Sanger Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sanger Sequencing Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sanger Sequencing Service Sales Value, 2019-2030
6.7.2 South Korea Sanger Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sanger Sequencing Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sanger Sequencing Service Sales Value, 2019-2030
6.8.2 Southeast Asia Sanger Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sanger Sequencing Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sanger Sequencing Service Sales Value, 2019-2030
6.9.2 India Sanger Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sanger Sequencing Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Profile
7.1.2 Thermo Fisher Main Business
7.1.3 Thermo Fisher Sanger Sequencing Service Products, Services and Solutions
7.1.4 Thermo Fisher Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Recent Developments
7.2 Azenta
7.2.1 Azenta Profile
7.2.2 Azenta Main Business
7.2.3 Azenta Sanger Sequencing Service Products, Services and Solutions
7.2.4 Azenta Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.2.5 Azenta Recent Developments
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Profile
7.3.2 Eurofins Scientific Main Business
7.3.3 Eurofins Scientific Sanger Sequencing Service Products, Services and Solutions
7.3.4 Eurofins Scientific Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.3.5 LGC Biosearch Technologies Recent Developments
7.4 LGC Biosearch Technologies
7.4.1 LGC Biosearch Technologies Profile
7.4.2 LGC Biosearch Technologies Main Business
7.4.3 LGC Biosearch Technologies Sanger Sequencing Service Products, Services and Solutions
7.4.4 LGC Biosearch Technologies Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.4.5 LGC Biosearch Technologies Recent Developments
7.5 Fasteris
7.5.1 Fasteris Profile
7.5.2 Fasteris Main Business
7.5.3 Fasteris Sanger Sequencing Service Products, Services and Solutions
7.5.4 Fasteris Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.5.5 Fasteris Recent Developments
7.6 QuintaraBio
7.6.1 QuintaraBio Profile
7.6.2 QuintaraBio Main Business
7.6.3 QuintaraBio Sanger Sequencing Service Products, Services and Solutions
7.6.4 QuintaraBio Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.6.5 QuintaraBio Recent Developments
7.7 Laragen
7.7.1 Laragen Profile
7.7.2 Laragen Main Business
7.7.3 Laragen Sanger Sequencing Service Products, Services and Solutions
7.7.4 Laragen Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.7.5 Laragen Recent Developments
7.8 Microsynth
7.8.1 Microsynth Profile
7.8.2 Microsynth Main Business
7.8.3 Microsynth Sanger Sequencing Service Products, Services and Solutions
7.8.4 Microsynth Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.8.5 Microsynth Recent Developments
7.9 Nucleics
7.9.1 Nucleics Profile
7.9.2 Nucleics Main Business
7.9.3 Nucleics Sanger Sequencing Service Products, Services and Solutions
7.9.4 Nucleics Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.9.5 Nucleics Recent Developments
7.10 GenScript Biotech
7.10.1 GenScript Biotech Profile
7.10.2 GenScript Biotech Main Business
7.10.3 GenScript Biotech Sanger Sequencing Service Products, Services and Solutions
7.10.4 GenScript Biotech Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.10.5 GenScript Biotech Recent Developments
7.11 CeMIA
7.11.1 CeMIA Profile
7.11.2 CeMIA Main Business
7.11.3 CeMIA Sanger Sequencing Service Products, Services and Solutions
7.11.4 CeMIA Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.11.5 CeMIA Recent Developments
7.12 StarSEQ
7.12.1 StarSEQ Profile
7.12.2 StarSEQ Main Business
7.12.3 StarSEQ Sanger Sequencing Service Products, Services and Solutions
7.12.4 StarSEQ Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.12.5 StarSEQ Recent Developments
7.13 Source BioScience
7.13.1 Source BioScience Profile
7.13.2 Source BioScience Main Business
7.13.3 Source BioScience Sanger Sequencing Service Products, Services and Solutions
7.13.4 Source BioScience Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.13.5 Source BioScience Recent Developments
7.14 Guangzhou Life Technologies DaAn
7.14.1 Guangzhou Life Technologies DaAn Profile
7.14.2 Guangzhou Life Technologies DaAn Main Business
7.14.3 Guangzhou Life Technologies DaAn Sanger Sequencing Service Products, Services and Solutions
7.14.4 Guangzhou Life Technologies DaAn Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.14.5 Guangzhou Life Technologies DaAn Recent Developments
7.15 SciGenom Labs
7.15.1 SciGenom Labs Profile
7.15.2 SciGenom Labs Main Business
7.15.3 SciGenom Labs Sanger Sequencing Service Products, Services and Solutions
7.15.4 SciGenom Labs Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.15.5 SciGenom Labs Recent Developments
7.16 Psomagen
7.16.1 Psomagen Profile
7.16.2 Psomagen Main Business
7.16.3 Psomagen Sanger Sequencing Service Products, Services and Solutions
7.16.4 Psomagen Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.16.5 Psomagen Recent Developments
7.17 Tsingke Biotechnology
7.17.1 Tsingke Biotechnology Profile
7.17.2 Tsingke Biotechnology Main Business
7.17.3 Tsingke Biotechnology Sanger Sequencing Service Products, Services and Solutions
7.17.4 Tsingke Biotechnology Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.17.5 Tsingke Biotechnology Recent Developments
7.18 GenHunter
7.18.1 GenHunter Profile
7.18.2 GenHunter Main Business
7.18.3 GenHunter Sanger Sequencing Service Products, Services and Solutions
7.18.4 GenHunter Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.18.5 GenHunter Recent Developments
7.19 CD Genomics
7.19.1 CD Genomics Profile
7.19.2 CD Genomics Main Business
7.19.3 CD Genomics Sanger Sequencing Service Products, Services and Solutions
7.19.4 CD Genomics Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.19.5 CD Genomics Recent Developments
7.20 Shanghai Personalbio Technology
7.20.1 Shanghai Personalbio Technology Profile
7.20.2 Shanghai Personalbio Technology Main Business
7.20.3 Shanghai Personalbio Technology Sanger Sequencing Service Products, Services and Solutions
7.20.4 Shanghai Personalbio Technology Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.20.5 Shanghai Personalbio Technology Recent Developments
7.21 Suzhou Hongxun Biotechnologies
7.21.1 Suzhou Hongxun Biotechnologies Profile
7.21.2 Suzhou Hongxun Biotechnologies Main Business
7.21.3 Suzhou Hongxun Biotechnologies Sanger Sequencing Service Products, Services and Solutions
7.21.4 Suzhou Hongxun Biotechnologies Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.21.5 Suzhou Hongxun Biotechnologies Recent Developments
7.22 Guangzhou IGE Biotechnology
7.22.1 Guangzhou IGE Biotechnology Profile
7.22.2 Guangzhou IGE Biotechnology Main Business
7.22.3 Guangzhou IGE Biotechnology Sanger Sequencing Service Products, Services and Solutions
7.22.4 Guangzhou IGE Biotechnology Sanger Sequencing Service Revenue (US$ Million) & (2019-2024)
7.22.5 Guangzhou IGE Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Sanger Sequencing Service Industrial Chain
8.2 Sanger Sequencing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sanger Sequencing Service Sales Model
8.5.2 Sales Channel
8.5.3 Sanger Sequencing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology
听
听
*If Applicable.